Three cases of ogilvie syndrome in chronic management with clozapine. San Juan de Dios Clinic, Chia, Colombia
Tres casos de síndrome de ogilvie en manejo crónico con clozapina. Clínica San Juan de Dios, Chía, Colombia
Article Sidebar
PDF (Español (España))
FLIP
Main Article Content
Abstract
Ogilvie syndrome is a clinical condition with signs, symptoms and radiographic findings of intestinal obstruction without a mechanical cause. The pathophysiology is still unknown, an imbalance between sympathetic and parasympathetic innervation of the colon is suggested. It is associated with a wide range of comorbidities including trauma, pelvic surgery (orthopedic, gynecological, urological), metabolic or central nervous system disorders, as well as drugs, especially atypical antipsychotics such as clozapine. Without timely diagnosis and treatment can progress to intestinal perforation, peritonitis and even death. We analyze the clinical histories of three patients treated for intestinal pseudo-obstruction (Ogilvie syndrome) at the San Juan de Dios Clinic in Chía, Colombia, in 2011, who required remission for medical or surgical management. The chronic use of the antipsychotic clozapine was considered as a triggering cause. The most serious complication was peritonitis and intestinal perforation, there was no mortality attributable to the syndrome or its management. Abbreviations: SO, Ogilvie syndrome
Downloads
Article Details
References
2. Cárdenas de la MR, Cárdenas G, Heredia C, Pizarro P. Manejo del Síndrome de Ogilvie. Rev Chil de Cir. 2004; 56: 103-6.
3. Tenofsky PL, Beamer L, Smith RS. Ogilvie Syndrome as postoperative complication. Arch Surg. 2000; 135(6): 682-6.
4. Avalos J, León C, Migueles C. Síndrome de Ogilvie ¿Qué hay de nuevo?. Rev Child Cir. 2001; 53: 220-25.
5. Quintero S, Chafeiro VM, Valdovinos D. Síndrome de Ogilvie o pseudo-obstrucción colónica aguda. Conceptos actuales en diagnóstico y tratamiento. Rev Gastroenterol Méx. 1997; 62: 119-1.
6. Ponec R, Saunders M, Kimmey M. Neostigmine for the treatment of acute colonic pseudo-obstruction. New Eng J Med. 1999; 341(Pt 3): 137-41.
7. Sloyer AF, Panella VS, Demas BE. Ogilvie’s syndrome: successful management with out colonoscopy. Dig Dis Sci. 1988; 33: 1391-6.
8. Montero L, Hormeño BR, González ME, Gordillo MB. The acute pseudobstruction of the colon or Ogilvie’s syndrome. Ann Med Int. 2006; 23: 435-7.
9. Vanek VW, Al Salti M. Acute pseudo obstruction of the colon (Ogilvie’s Syndrome): an analysis of 400 cases. Dis Colon Rectum. 1986; 29: 203-10.
10. Perez BF, Dominguez VJ, Fernandez GC. Ogilvie’s Syndrome: A motily Distubance?.Rev Esp Enf Digest. 1990; 78: 106-10.
11. Walwaikar PP, Kulkarni SS, Bargaje RS. Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study. J Indian Med Assoc. 2005; 103: 708-9.
12. Rex DK. Colonoscopy and acute colonic pseudo-obstruction. Gastrointest Endosc Clin Noorth Am. 1997; 7: 499-508.
13. Johnson CD, Rice RP, Kelvin FM, Foster W.L. The Radiographic evaluation of gross cecal distention: emphasis on cecal ileus. AJR Am J Roentgenol. 1985; 145: 1211-17.
14. Trevisani GT, Hyman NH, Church JM. Neostigmine: safe and effective treatment of acute pseudo-obstruction. Dis Colon Rectum. 2000; 43: 1454.
15. Delgado AS, Camilleri M. Clinical management of acute colonic pseudo-obstruction in patient: a systemic review of literature. Gastroenterol Hepatol. 2003; 26: 646-55.
16. Cross JM, Marvin RG. Acute colonic Pseudo-obstruction in a Patient with a Significant Closed Head Injury. Internet J Emerg Int Care Med. 2000: 4 (Pt 1).
17. Bognel JC, Fasano JJ. Colonic pseudo-occlusion syndrome.Ogilvie ́s syndrome. Apropos of 22 cases. Ann Gastroenterol Hepatol. 1984; 20: 157-61.
18. Rondeau M, Weber JC, Nodot I, Storck D. Acute colonic pseudo-obstruction in internal medicine: etiology and prognosis, report of a retrospective study. Rev Med Intern. 2001; 22: 536-41.